HY-101664-10mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
HY-101664-100mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
HY-101664-2mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
HY-101664-5mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
HY-101664-50mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
HY-102001-10mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-25mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-5mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-50mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-106662-10mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-106662-100mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-106662-25mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-106662-5mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-106662-50mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-100mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-25mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-250mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-131326-50mg
|
MedChemexpress LLC
|
DOTA-tris(tBu)ester NHS ester [CAS 819869-77-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-10mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-100mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-25mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-5mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-50mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-138632-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
HY-138632-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|